Prostatype Genomics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	12.93	9.42	2.68	4.81	9.83	15.86
Short-Term Investments	-	-	-	6.68	10.5	-
Cash & Short-Term Investments	12.93	9.42	2.68	11.49	20.33	15.86
Cash Growth	624.48%	251.23%	-76.66%	-43.48%	28.16%	84.42%
Accounts Receivable	-	0.04	0.21	0.5	0.15	0.34
Other Receivables	1.27	1.07	1.02	1.66	0.5	0.58
Receivables	1.27	1.11	1.23	2.16	0.65	0.91
Inventory	0.17	0.1	0.2	0.18	0.18	0.39
Prepaid Expenses	-	0.67	0.3	0.34	0.42	0.28
Other Current Assets	-	0.53	21.49	0	-	-0
Total Current Assets	14.37	11.83	25.91	14.17	21.59	17.46
Property, Plant & Equipment	0.48	0.31	0.06	0	0.01	0.03
Other Intangible Assets	28.52	2.68	-	-	0.04	0.11
Long-Term Deferred Charges	-	26.59	23.18	16.71	18.57	16.07
Other Long-Term Assets	0.47	0.57	0.07	0.07	-	-
Total Assets	43.84	41.97	49.22	30.95	40.2	33.66
Accounts Payable	-	2.52	9.45	2.18	1.17	1.78
Accrued Expenses	-	3.21	2.92	1.05	0.84	1.32
Short-Term Debt	-	-	11.2	-	-	-
Current Portion of Long-Term Debt	-	0.07	0.4	0.4	0.4	0.4
Current Income Taxes Payable	-	0.05	0.1	0.24	0.18	0.06
Other Current Liabilities	7.36	2.65	0.41	0.46	0.84	0.75
Total Current Liabilities	7.36	8.5	24.48	4.33	3.43	4.31
Long-Term Debt	-	-	0.07	0.47	0.87	1.07
Other Long-Term Liabilities	-	-	-0	-0	-	-
Total Liabilities	7.36	8.5	24.55	4.8	4.3	5.37
Common Stock	3.7	0.67	7.17	1.37	0.91	0.79
Additional Paid-In Capital	204.43	183.69	177.15	149.32	130.45	107.32
Retained Earnings	-	-	-	-	-95.45	-79.82
Comprehensive Income & Other	-171.65	-150.89	-159.65	-124.54	-0	-
Shareholders' Equity	36.48	33.47	24.67	26.15	35.91	28.29
Total Liabilities & Equity	43.84	41.97	49.22	30.95	40.2	33.66
Total Debt	-	0.07	11.67	0.87	1.27	1.47
Net Cash (Debt)	12.93	9.35	-8.99	10.62	19.06	14.4
Net Cash Growth	624.48%	-	-	-44.28%	32.42%	374.87%
Net Cash Per Share	1.36	6.63	-111.17	583.53	1348.32	-
Filing Date Shares Outstanding	37	6.7	0.12	0.02	0.02	0.01
Total Common Shares Outstanding	37	6.7	0.12	0.02	0.02	0.01
Working Capital	7.01	3.32	1.43	9.84	18.15	13.15
Book Value Per Share	0.99	4.99	206.55	1144.01	2379.60	2145.32
Tangible Book Value	7.97	30.79	24.67	26.15	35.87	28.18
Tangible Book Value Per Share	0.22	4.59	206.55	1144.01	2377.14	2136.86
Machinery	-	0.78	0.56	0.73	0.73	0.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.